We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Signs of Alzheimer’s Disease: Tied to Aging
Summary
This review explores the core biological mechanisms that connect aging to Alzheimer's disease, including abnormal protein buildup, chronic brain inflammation, loss of key neurotransmitters, and blood-brain barrier dysfunction. Researchers highlight how age-related decline in the body's ability to clear waste and repair cellular damage accelerates the progression of neurodegeneration. The study underscores the need for treatments that target multiple pathways simultaneously rather than addressing a single mechanism.
: Alzheimer's disease (AD) is a neurodegenerative disorder closely associated with aging, and its pathogenesis involves the interaction of multidimensional pathophysiologic processes. This review outlines the core mechanisms linking aging and AD. The amyloid cascade hypothesis emphasizes that abnormal deposition of amyloid-β (Aβ) triggers neuronal damage and synaptic dysfunction, which is exacerbated by aging-associated declines in protein clearance. Neuroinflammation, a synergistic pathogenetic factor in AD, is mediated by microglia activation, creating a vicious cycle with Aβ and tau pathology. The cholinergic hypothesis states that the degeneration of cholinergic neurons in the basal forebrain can lead to acetylcholine deficiency, which is directly associated with cognitive decline. Endothelial disorders promote neuroinflammation and metabolic waste accumulation through blood-brain barrier dysfunction and cerebral vascular abnormalities. In addition, glutamate-mediated excitotoxicity and mitochondrial dysfunction (e.g., oxidative stress and energy metabolism imbalance) further lead to neuronal death, and aging-associated declines in mitochondrial autophagy exacerbate such damage. This review also explores the application of animal models that mimic AD and aging in studying these mechanisms and summarizes therapeutic strategies targeting these pathways. Future studies need to integrate multi-targeted therapies and focus on the role of the aging microenvironment in regulating AD pathology in order to develop more effective early diagnosis and treatment options.
Sign in to start a discussion.
More Papers Like This
Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders
This review paper summarizes existing research showing that as we age, our brain cells and immune system deteriorate in ways that may contribute to diseases like Alzheimer's and Parkinson's. The aging process causes harmful inflammation in the brain, and scientists have identified specific biological markers that signal this damage is happening. Understanding these aging patterns could help researchers develop new treatments called "senolytic therapies" that target and remove damaged aging cells to potentially slow or prevent brain diseases.
Alzheimer’s disease: the role of extrinsic factors in its development, an investigation of the environmental enigma
This review examines how environmental contaminants, including microplastics, may contribute to Alzheimer's disease risk. Along with air pollutants, toxic metals, and pesticides, plastics and microplastics are identified as potential risk factors that may promote brain inflammation and neurodegeneration. The review explores the molecular mechanisms behind these effects and suggests strategies to reduce the brain health impacts of environmental contaminants.
The Role of Emerging Environmental Contaminants on Alzheimer’s Disease
This review examined the role of emerging environmental contaminants, including microplastics, in the development and progression of Alzheimer's disease. The authors discussed mechanisms including oxidative stress, neuroinflammation, and blood-brain barrier disruption as potential pathways linking environmental exposures to AD pathogenesis.
Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
Researchers reviewed natural bioactive compounds from plant sources for their potential neuroprotective effects related to Alzheimer's disease. The study highlights how these compounds may modulate molecular mechanisms involved in disease development, while noting challenges such as limited bioavailability and blood-brain barrier permeability.
Alzheimer's Disease: New Perspectives
This review of Alzheimer's disease research challenges the dominant amyloid hypothesis and examines evidence that toxic environmental exposures — including microplastics and their chemical additives — may contribute to disease risk, arguing for broader investigation of environmental factors in neurodegeneration.